Follow-up of Patients After Knee Arthrodesis With an Intramedullary Nail

This study is currently recruiting participants.
Verified January 2013 by University Hospital, Ghent
Sponsor:
Information provided by (Responsible Party):
University Hospital, Ghent
ClinicalTrials.gov Identifier:
NCT00284297
First received: January 30, 2006
Last updated: January 29, 2013
Last verified: January 2013
  Purpose

Follow-up of patients who underwent a knee arthrodesis with different types of intramedullary nails.


Condition Intervention
Knee Arthrodesis With Intramedullary Nail
Procedure: History taken and clinical examination

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Follow-up of Patients After Knee Arthrodesis With an Intramedullary Nail

Further study details as provided by University Hospital, Ghent:

Primary Outcome Measures:
  • Follow-up of patients who underwent a knee arthrodesis with different types of intramedullary nails [ Time Frame: t0 ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 20
Study Start Date: September 2005
Estimated Study Completion Date: July 2013
Estimated Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: knee arthrodesis Procedure: History taken and clinical examination
History is taken and clinical examination is followed

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • All patients who underwent a knee arthrodesis with an intramedullary nail between 1994 and 2005

Exclusion Criteria:

-

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00284297

Contacts
Contact: René Verdonk, MD, PhD + 32 9 332.22.48 rene.verdonk@ugent.be

Locations
Belgium
University Hospital Ghent Recruiting
Ghent, Belgium, 9000
Contact: René Verdonk, MD, PhD    + 32 9 332.22.48    rene.verdonk@ugent.be   
Principal Investigator: René Verdonk, MD, PhD         
Sponsors and Collaborators
University Hospital, Ghent
Investigators
Principal Investigator: René Verdonk, MD, PhD University Hospital, Ghent
  More Information

Additional Information:
No publications provided

Responsible Party: University Hospital, Ghent
ClinicalTrials.gov Identifier: NCT00284297     History of Changes
Other Study ID Numbers: 2005/213
Study First Received: January 30, 2006
Last Updated: January 29, 2013
Health Authority: Belgium: Institutional Review Board

ClinicalTrials.gov processed this record on April 15, 2014